YF-VAX 1 dose vials
Ended Awarded
- Contract number
- SPE2DB25FQRP7
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,113
Award facts
- Contract value 100% obligated
- $1,113.42 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, valued at $1,113.42, represents a firm fixed-price award issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc. for the supply of YF-VAX 1 Dose Vials, a yellow fever vaccine product. The contract carries an ultimate completion date of September 23, 2025, and was awarded on September 2, 2025, with no set-aside designation applied. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform fulfillment from its location in Park Ridge, IL. The company leverages its position as a vendor under the DLA's larger SPE2DB Indefinite Delivery Contract (IDC), a $499.999 billion single-award vehicle that enables the agency to issue delivery orders for a comprehensive range of pharmaceutical products supporting military health facility requirements worldwide.
This award reflects DMS Pharmaceutical Group's established role within the federal pharmaceutical supply chain, where it specializes in distributing branded and generic prescription drugs, biologics, vaccines, and medical consumables to Department of Defense healthcare facilities. The company's consistent procurement success with the DLA, coupled with its woman-owned small business status, has positioned it as a key supplier for medical supply needs across military installations. The YF-VAX delivery order represents one of numerous vaccine and pharmaceutical product awards the company has secured, demonstrating its capability to fulfill time-sensitive medical supply requirements for federal healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FQRP7?
SPE2DB25FQRP7 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 2, 2025.
How much is contract SPE2DB25FQRP7 worth?
The government has obligated $1,113 on SPE2DB25FQRP7.
Is contract SPE2DB25FQRP7 an order under another contract?
Yes. SPE2DB25FQRP7 is a delivery order under SPE2DB20D9201, an indefinite delivery contract.
Was contract SPE2DB25FQRP7 competed?
The extent of competition for SPE2DB25FQRP7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award